Financial News

Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

22.73 -0.61 (-2.63%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 135,211
Open 23.86
Bid (Size) 22.55 (1)
Ask (Size) 22.87 (1)
Prev. Close 23.34
Today's Range 22.57 - 24.38
52wk Range 13.30 - 30.03
Shares Outstanding 41,151,111
Dividend Yield N/A

Performance

YTD
-4.9%
-4.9%
1 Month
+4.2%
+4.2%
3 Month
+37.5%
+37.5%
6 Month
+3.3%
+3.3%
1 Year
-4.4%
-4.4%

More News

Read More

Frequently Asked Questions

Is Enliven Therapeutics, Inc. - Common Stock publicly traded?
Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?
Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?
The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market
What is the current price of Enliven Therapeutics, Inc. - Common Stock?
The current price of Enliven Therapeutics, Inc. - Common Stock is 22.73
When was Enliven Therapeutics, Inc. - Common Stock last traded?
The last trade of Enliven Therapeutics, Inc. - Common Stock was at 07/18/25 01:00 PM ET
What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?
The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 935.16M
How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?
Enliven Therapeutics, Inc. - Common Stock has 935M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback